Aster DM Quality Care: Board's approval for conversion of a pre-existing loan extended by the Company to Sri Sainatha…
Aster DM Quality Care (ASTERDM) filed a disclosure titled "Board's approval for conversion of a pre-existing loan extended by the Company to Sri Sainatha Multispeciality Hospitals Private Limited ( Sri Saintha ), a wholly owned…". The company is valued at…
What happened
Aster DM Quality Care (ASTERDM) filed a disclosure with the exchanges on 6 November 2026 at 07:31 PM titled "Board's approval for conversion of a pre-existing loan extended by the Company to Sri Sainatha Multispeciality Hospitals Private Limited ( Sri Saintha ), a wholly owned…".
Company snapshot
Aster DM Quality Care is a mid-cap company in the Healthcare sector, with a market value of about ₹62,163 crore.
The stock last traded at ₹713.2, against a 52-week range of ₹519.1–₹891.3 (20.0% below the high).
Before this filing the shares had moved +4.1% over the month and −14.8% over three months. Average daily turnover over the last 20 sessions was about ₹59.45 crore.
Promoters held 53.72% at the end of Q2 FY27, up 13.33% points from the previous quarter; 18.17% of promoter shares were pledged. Foreign institutions owned 10.31% and domestic institutions 16.48%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,078 | 85.5 | 1.67 |
| Q2 FY26 | 1,197 | 110 | 2.13 |
| Q3 FY26 | 1,186 | 52.5 | 1.02 |
| Q4 FY26 | 1,182 | 140.2 | 2.72 |
| Q1 FY27 | 1,311 | 16.1 | 0.31 |
What history shows
BCEIE's records show 10 previous m&a filings from the company since May 2026.
After those filings, the stock gained 1.3% on average the next trading day and was up 2.0% on average after five days (8 filings with price data).
Across 152 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +0.8% over five days; 57% of them rose the next day.
Market-wide, 2,364 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 29 Aug 2026 | Approval Of Scheme Of Amalgamation Of Step-Down Subsidiaries Of The… | +1.3% | +6.3% |
| 28 Aug 2026 | M&A | +1.3% | +6.3% |
| 5 Aug 2026 | Acquisition of equity shares of United CIIGMA Institute of Medical… | +3.3% | −2.1% |
| 1 Jul 2026 | M&A | +2.2% | +4.0% |
| 1 Jul 2026 | Update On Scheme Of Amalgamation Of The Company With Regard To… | +2.2% | +4.0% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- ASTERDM Share Price Today - Aster DM Quality Care on NSE/BSE
- Aster DM Quality Care Limited (ASTERDM.NS) Seasonal returns chart - Yahoo Finance
- Centella Mauritius sells 7.16% stake in Aster DM Quality Care
- Aster DM Quality Care Q2 FY27 Earnings Call Date
- Aster DM Quality Care Ltd Surges 5.33% to Day's High of Rs 720.4 — Outperforms Sector by 3.76 Percentage Points
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.